318P EMPOWER-Lung 3: Cemiplimab in combination with platinum doublet chemotherapy for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC)

ANNALS OF ONCOLOGY(2022)

引用 14|浏览1
暂无评分
关键词
platinum doublet chemotherapy,empower-lung cancer,first-line,non-small
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要